Why did Kinsale authorize a $250 million buyback in July 2026?

Kinsale's Board approved the authorization due to the company's generation of significant operating cash flows and resulting excess capital. CEO Michael Kehoe stated the company is "generating significant operating cash flows resulting in excess capital" while maintaining its strategy of disciplined underwriting and technology-enabled low costs.

How much buyback capacity does Kinsale have remaining?

Following the new $250 million authorization in July 2026, Kinsale has $337.5 million in remaining capacity under its share repurchase program. This total reflects both the new authorization and any prior remaining balances.

What did Kinsale actually repurchase in Q2 2026?

During the second quarter of 2026, Kinsale repurchased 321,055 shares at an average price of $311.47 per share for a total cost of $100.0 million. The repurchases were executed in the open market under the company's existing authorization.

How does Kinsale's buyback fit into its overall capital return strategy?

Kinsale combines share repurchases with cash dividends. In Q2 2026, the company declared and paid a $0.25 per share dividend in addition to the $100 million in open-market share buybacks, demonstrating a balanced approach to returning capital to stockholders.

What were Kinsale's Q2 2026 financial results?

Kinsale reported net income of $175.9 million ($7.72 per diluted share) in Q2 2026, up 34% from $5.76 per diluted share in Q2 2025. The company also achieved a combined ratio of 75.5% and an annualized return on equity of 28.9% for the first half of 2026.

Does the earnings release specify how the buyback will be executed?

The filing does not explicitly state the execution mechanism in the buyback authorization language. However, the Q2 2026 repurchases ($100 million for 321,055 shares) were described as open-market purchases, and no alternative method (such as ASR or tender offer) is mentioned for the new $250 million authorization.

KNSL 8-K Filed 2026-07-23 New authorization

Kinsale Capital authorizes $250M share repurchase program

Board approves new buyback authorization as insurer reports strong Q2 2026 earnings and excess capital

Authorization$250M

Remaining$338M

MechanismRule 10b-18 open-market purcha

What the filing says

Kinsale Capital Group, Inc. (NYSE: KNSL) announced in July 2026 that its Board of Directors approved an additional $250 million share repurchase authorization, bringing the remaining capacity under the company's share repurchase program to $337.5 million total. The authorization was disclosed in the company's second quarter 2026 earnings release filed as an exhibit to an 8-K on July 23, 2026.

The timing of the authorization reflects Kinsale's strong financial position. In the second quarter of 2026, the company reported net income of $175.9 million ($7.72 per diluted share) and generated significant operating cash flows, creating what management characterized as "excess capital." During Q2 2026, the company also repurchased 321,055 shares at an average price of $311.47 per share for $100.0 million in total cost under existing authorization.

CEO Michael P. Kehoe stated in the earnings release that "we are generating significant operating cash flows resulting in excess capital and are pleased to report an additional share repurchase authorization of $250 million." The company continues to focus on capital return to stockholders through both share repurchases and dividends—declaring and paying a $0.25 per share cash dividend in Q2 2026.

In July 2026, the Company's Board of Directors approved an additional $250 million share repurchase authorization, bringing the remaining capacity to $337.5 million under the share repurchase program. — Kinsale Capital Group, Inc. 8-K filing · View on SEC EDGAR →

What this means

The new $250 million authorization represents Kinsale's commitment to return capital to shareholders amid strong profitability and cash generation. In Q2 2026, the company already spent $100 million repurchasing 321,055 shares at an average price of $311.47, demonstrating active execution under prior authorization. With stockholders' equity at $2.0 billion and an annualized return on equity of 28.9% for the first half of 2026, the company has substantial capital relative to its operations. The authorization signals management confidence in the company's financial strength and its ability to deploy excess capital while maintaining underwriting discipline.

Frequently asked questions

Why did Kinsale authorize a $250 million buyback in July 2026?: Kinsale's Board approved the authorization due to the company's generation of significant operating cash flows and resulting excess capital. CEO Michael Kehoe stated the company is "generating significant operating cash flows resulting in excess capital" while maintaining its strategy of disciplined underwriting and technology-enabled low costs.
How much buyback capacity does Kinsale have remaining?: Following the new $250 million authorization in July 2026, Kinsale has $337.5 million in remaining capacity under its share repurchase program. This total reflects both the new authorization and any prior remaining balances.
What did Kinsale actually repurchase in Q2 2026?: During the second quarter of 2026, Kinsale repurchased 321,055 shares at an average price of $311.47 per share for a total cost of $100.0 million. The repurchases were executed in the open market under the company's existing authorization.
How does Kinsale's buyback fit into its overall capital return strategy?: Kinsale combines share repurchases with cash dividends. In Q2 2026, the company declared and paid a $0.25 per share dividend in addition to the $100 million in open-market share buybacks, demonstrating a balanced approach to returning capital to stockholders.
What were Kinsale's Q2 2026 financial results?: Kinsale reported net income of $175.9 million ($7.72 per diluted share) in Q2 2026, up 34% from $5.76 per diluted share in Q2 2025. The company also achieved a combined ratio of 75.5% and an annualized return on equity of 28.9% for the first half of 2026.
Does the earnings release specify how the buyback will be executed?: The filing does not explicitly state the execution mechanism in the buyback authorization language. However, the Q2 2026 repurchases ($100 million for 321,055 shares) were described as open-market purchases, and no alternative method (such as ASR or tender offer) is mentioned for the new $250 million authorization.

authorization specialty-insurance excess-capital rule-10b-18 open-market Q2-2026

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.